For genes that regulate the degradation of the atypical myrosinase metabolic pathway, the expression of PEN2 was downregulated by the TB and GB treatments; the expression of PEN3 was downregulated by the GB treatment, followed by the TB and BB treatments. This evidence concerns the gene PSENEN and tuberculosis.